IMNM Market Cap & Key Metrics
Immunome, Inc.
$17.57
+$0.37(+2.15%)
40
Overall
50
Value
18
Tech
52
Quality
Market Cap
$2.03B
Volume
253.69K
52W Range
$13.53 - $30.06
Target Price
$35.20
IMNM market cap is $2.03B. This page lists Immunome, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
IMNM Key Metrics
- Market cap
- $2.03B
- EPS estimate, current year
- $-2.51
- EPS growth, 3-year
- +7.70%
- Value score
- 50
- Quality score
- 52
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.94M | $9.04M | $14.02M | - | - |
| EBITDA | -$221.12M | -$303.67M | -$108.76M | -$36.29M | -$24.45M |
| EPS | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMNM | $17.57 | +2.2% | 253.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |